TRIAL RESULTS · SIDE EFFECTS

Sermorelin side effects

ANSWER

No trial of Sermorelin has posted side-effect results on ClinicalTrials.gov (27 registered). Read on 2026-10-03. Not medical advice.

Trial register

Trials with posted results

0

with an arm on Sermorelin, of 27 registered

Against placebo

0

placebo-controlled trials

People in those trials

0

on Sermorelin · 0 on placebo

Read

2026-10-03

ClinicalTrials.gov

TRIAL RESULTS

No posted side-effect results

None of the 27 registered trials of Sermorelin has posted side-effect results with an arm on Sermorelin to ClinicalTrials.gov. Read 2026-10-03.

REGISTERED STUDIES

27 registered clinical trials of Sermorelin

The 10 most recently updated are listed.

NCT06554717
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
Status: RECRUITING · Updated 2026-05-19
NCT03375788
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
Status: COMPLETED · Updated 2025-11-20
NCT00720902
Adult Growth Hormone Deficiency and Cardiovascular Risk
Status: TERMINATED · Updated 2022-11-16
NCT00608023
TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy
Status: COMPLETED · Updated 2022-09-30
NCT02196831
Tesamorelin Effects on Liver Fat and Histology in HIV
Status: COMPLETED · Updated 2020-01-27
NCT02553603
The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment
Status: COMPLETED · Updated 2019-11-04
NCT00791843
The Effect of GHRH Therapy on Myocardial Structure and Function in Congestive Heart Failure
Status: COMPLETED · Updated 2019-07-09
NCT01410799
Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly
Status: TERMINATED · Updated 2019-05-24
NCT00675506
Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese
Status: COMPLETED · Updated 2017-12-13
NCT01263717
Effects of Growth Hormone Releasing Hormone in HIV
Status: COMPLETED · Updated 2017-10-30

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.